Liposome Drug Delivery Market Report, Analysis, Opportunities by 2031
The Liposome Drug DeliveryMarket was valued at US$ 4.2 billion in 2021 and is expected to reach US$ 11.5 billion by 2031. The market is expected to register a CAGR of 8.3% from 2023–2031. Fast regulatory approval is likely to remain key Liposome Drug Delivery Market trends.
Liposome Drug DeliveryMarket Analysis
Liposome Drug Delivery in Cancer Therapy
Liposomes have revolutionized cancer therapy due to their broad applications. For example, liposomes were the first nanotechnology-based drug delivery system approved for clinical applications due to their biocompatibility and biodegradability features. Also, liposomes have established themselves in nanocarrier-based drug delivery systems for successful clinical applications of liposomal formulation for anti-cancer therapy. Additionally, liposomal drugs have high encapsulation properties, showing significant anticancer activity by decreasing toxicity and, specifically, cardiotoxicity. Such liposomal treatment encapsulation technique (encapsulation) shows great prolonged circulation similar to "Daunorubicin" and "Pegylated Liposomal Doxorubicin". The aforementioned factors are responsible for influential liposome drug delivery market growth during 2021-2031.
Liposome Drug DeliveryMarket Overview
Technology, innovation, and smart technological solutions such as continue to influence liposome drug delivery significantly. Liposome drug delivery in cancer therapy and efficient product launches for liposome drug deliveryare the most influential factors responsible for Liposome Drug Delivery Market growth. Fast regulatory approval is a key trend for Liposome Drug Delivery Market growth. Research & Development (R&D) activitieswill provide lucrative market opportunity.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Liposome Drug Delivery Market: Strategic Insights
Market Size Value in US$ 3,594.41 Million in 2019 Market Size Value by US$ 6,992.95 Million by 2027 Growth rate CAGR of 8.8% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Liposome Drug Delivery Market: Strategic Insights
| Market Size Value in | US$ 3,594.41 Million in 2019 |
| Market Size Value by | US$ 6,992.95 Million by 2027 |
| Growth rate | CAGR of 8.8% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Liposome Drug DeliveryMarket Drivers and Opportunities
Efficient Product Launches for Liposome Drug Delivery to Favor Market
- In October 2021, Evonik announced the launching of the next-generation "LIPEX EXTRUDER" for fast and effective liposomal drug manufacturing. LIPEX provides high throughput and faster batch production times for liposomal drug delivery formulations.
- In January 2022, Pfizer and Acuitas Therapeutics announced a strategic collaboration for Acuita's "Lipid Nanoparticle (LNP) Technology" for potential utilization. The technology holds promise for both vaccine and therapeutic development, focussing on Pfizer's commitment to innovative solutions and paying the way for novel advancements in the field.
Therefore, efficient product launches and strategic collaboration for liposome drug delivery will contribute significantly in the coming years.
Research & Development (R&D) Activities for Liposome Drug Delivery Market– An Opportunity
The top manufacturers developing liposome drug delivery are capitalizing focus on R&D activities for developing nanomaterials, nanospheres, liposomes, and nanoparticles. Such liposome drug delivery can leverage in-vivo and in-vitro drug activities for routine clinical practices. Since the discovery of first-generation liposomes, lipid nanoparticles (LNPs) have evolved tremendously with high adoption in the pharmaceutical industry. For example, Stimuli-responsive liposomes are another approach currently under investigation that enhances drug delivery in tumors, whereas they are designed to be released under certain physiochemical or biochemical stimuli. Examples include "Doxorubicin," "5-fluorouracil", and "AMD3100". Additionally, future research involves a number of Phase 1/2 clinical trials currently investigating LNP formulation as a cancer immunotherapy target for solid tumors, including melanoma, adult glioblastoma, gastrointestinal cancer, and genitourinary cancer, focussing on broad clinical use. Therefore, R&D activities provide lucrative market opportunities accounting considerable market share in the coming years for Liposome Drug Deliverymarket.
Liposome Drug Delivery
Market Report Segmentation Analysis
Key segments that contributed to the derivation of the Liposome Drug Delivery Market analysis are candidature and services.
- Based on Product, the Liposome Drug Delivery Market is segmented into liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin b, and others. The liposomal doxorubicin may hold a larger market share in 2023.
- Based on Technology, the Liposome Drug Delivery Market is segmented into stealth liposome technology, non-pegylated liposome technology, depofoam liposome technology, lysolipid thermally sensitive liposome. The stealth liposome technology may hold a larger market share in 2023.
- Based on Application, the Liposome Drug Delivery Market is segmented into fungal diseases, cancer therapy, pain management, viral vaccines, and photodynamic therapy. The cancer therapy may hold a larger market share in 2023.
Liposome Drug Delivery Market Share Analysis by Geography
The geographic scope of the Liposome Drug DeliveryMarket report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.
North America has dominated the Liposome Drug Delivery Market. In North America, US accounts considerable share for liposome drug delivery. Presence of top medical biotechnology and biopharmaceutical players in the US. Additionally, presence of Contract Research Organizations (CROs) is one of the most influential factors responsible for market growth. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.
Liposome Drug Delivery
Market Report Scope
Liposome Drug DeliveryMarket News and Recent Developments
The Liposome Drug DeliveryMarket is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in them market for Liposome Drug Delivery and strategies:
- In June 2022, Endo Internal Plc's subsidiary company "Endo Ventures Limited (EVL)" and Taiwan Liposome Company, Ltd. (TLC) announced collaboration to commercialize "TLC599" an investigational product by TLC. Currently, TLC599 is an injectable compound designed to address osteoarthritis knee pain showcasing the continuous efforts to advance treatment options in the therapeutic area.
Liposome Drug DeliveryMarket Report Coverage and Deliverables
The “Liposome Drug DeliveryMarket Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product ; Technology ); Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Aregntina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For